Cite
HARVARD Citation
Gow, J. et al. (2015). Safety, tolerability, pharmacokinetics, and efficacy of AMG 403, a human anti-nerve growth factor monoclonal antibody, in two phase I studies with healthy volunteers and knee osteoarthritis subjects. Arthritis research & therapy. 17 (1), pp. 1-11. [Online].